PHARMPROTECH HOLDING ApS: Financial statements 2024
CVR: 29174644
Source: annual report 2024, Danish Business Authority
01/10/2023 – 30/09/2024
PHARMPROTECH HOLDING ApS (CVR 29174644) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -163,685 and a net result of DKK 5,877,922 compared with DKK 5,189,592 the year before. Equity in the 2024 report amounted to DKK 34,598,042. The solvency ratio was 85.4%.
- Gross Profit
- DKK -163,685
- Profit/Loss
- DKK 5,877,922
- Equity
- DKK 34,598,042
- Total Assets
- DKK 40,530,917
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -164 t. | 5.9 mio. | 34.6 mio. | - |
| 2023 | - | -17 t. | 5.2 mio. | 28.8 mio. | - |
| 2022 | - | -10 t. | 5.6 mio. | 23.6 mio. | - |
| 2021 | - | -10 t. | 1.3 mio. | 18.1 mio. | - |
| 2020 | - | -6 t. | 5.4 mio. | 16.8 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout PHARMPROTECH HOLDING ApS
PHARMPROTECH HOLDING ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2005. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Tony Christensen. The company is owned by Tony Christensen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -767,188 and a net result of DKK 3,595,179 compared with DKK 5,877,922 the year before. Equity in the 2025 report amounted to DKK 38,132,221.